Open Access Articles

Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients

, 2017; 15(6): 448 - 455

Isabella Bon, Leonardo Calza, Giuseppina Musumeci, Serena Longo, Alessia Bertoldi, Vanessa D`Urbano, Davide Gibellini, Eleonora Magistrelli, Pier Luigi Viale and Maria Carla Re*




Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial

, 2017; 15(3): 216 - 224

Joel Gallant*, Graeme Moyle, Juan Berenguer, Peter Shalit, Huyen Cao, Ya-Pei Liu, Joel Myers, Lisa Rosenblatt, Lingfeng Yang and Javier Szwarcberg




Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field

, 2017; 15(3): 202 - 215

Bruce D. Wines, Hugh Billings, Milla R. Mclean, Stephen J. Kent and P. Mark Hogarth*




HIV Risk Behavior and Prevention Considerations Among Military Personnel in Three Caribbean Region Countries: Belize, Barbados, and the Dominican Republic

, 2017; 15(3): 154 - 160

Nakisa Asefnia*, Lisa Cowan and Rose Werth




HIV/AIDS Securitization: Outcomes and Current Challenges

, 2017; 15(2): 78 - 81

Aladdin H. Shadyab*, Braden R. Hale and Richard A. Shaffer




Effect of the Modification of p24 Peptide Antigen on Dendritic Cell Uptake and T Cell Activation

, 2017; 15(1): 3 - 14

Peter L. Smith, Kirstie J. Norgate, Eve Hegarty, Nathalie Gregeda, Edward Heelas, Maja Sommerfelt, Tonnes Lange, Arnt-Ove Hovden, Birger Sorenson, Angus G. Dalgleish and Mark Bodman-Smith




Prevalence of HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Nepal

, 2016; 14(6): 517 - 524

Nirajan Bhusal, Ruengpung Sutthent*, Navin Horthongkham, Niracha Athipanyasilp and Wannee Kantakamalakul




Astrocytes as an HIV Reservoir: Mechanism of HIV Infection

, 2016; 14(5): 373 - 381

Guan-Han Li, Lisa Henderson and Avindra Nath




Persistent But Not Replicating HIV-1 Cell-Associated DNA in Semen of Long-Term ART Experienced Men

, 2016; 14(4): 316 - 323

Amandine Gagneux-Brunon, Dorsaf Nasri, Rachel Terrasse, Karine Sauné, Marie-Claude Gagnieu, Anne Frésard, Olivier Delezay, Jacques Izopet, Bruno Pozzetto, Frédéric Lucht and Thomas Bourlet




Cellular Antiviral Factors that Target Particle Infectivity of HIV-1

, 2016; 14(3): 211 - 216

Christine Goffinet




The Early Bird Catches the Worm – Can Evolution Teach us Lessons in Fighting HIV?

, 2016; 14(3): 183 - 210

Torsten Schaller and Nikolas Herold




Perspectives of Genome-Editing Technologies for HIV Therapy

, 2016; 14(1): 2 - 8

Hirotaka Ebina, Peter Gee and Yoshio Koyanagi




Effects of a Quasi-Randomized Web-Based Intervention on Risk Behaviors and Treatment Seeking Among HIV-Positive Men Who Have Sex With Men in Chengdu, China

, 2015; 13(6): 490 - 496

Guodong Mi, Zunyou Wu, Xiaodong Wang, Cynthia X. Shi, Fei Yu, Tian Li, Linglin Zhang, Jennifer M. McGoogan, Lin Pang, Jie Xu and Keming Rou




Brief Messages to Promote Prevention and Detection of Sexually Transmitted Infections

, 2015; 13(5): 408 - 420

Rocio Garcia-Retamero and Edward T. Cokely




Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria

, 2015; 13(4): 300 - 307

Chinenye Ugoji, Nwanneka Okere, Patrick Dakum, Rukeme Ake-Uzoigwe, Donald Igboelina, Nicaise Ndembi, Ernest Ekong, Manhattan Charurat and William A. Blattner




HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective

, 2015; 13(3): 250 - 257




Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs

, 2015; 13(3): 244 - 246

Barrot H. Lambdin, Ben Cheng, Trevor Peter, Jessie Mbwambo, Tsitsi Apollo, Megan Dunbar, Ifeoma C. Udoh, Adithya Cattamanchi, Elvin H. Geng and Paul Volberding




Opiate Addiction Therapies and HIV-1 Tat: Interactive Effects on Glial [Ca2+]i, Oxyradical and Neuroinflammatory Chemokine Production and Correlative Neurotoxicity

, 2014; 12(6): 424 - 434

Sylvia Fitting, Shiping Zou, Nazira El-Hage, Masami Suzuki, Jason J. Paris, Christina J. Schier, Jose W. Rodriguez, Myosotys Rodriguez, Pamela E. Knapp and Kurt F. Hauser




Heme Oxygenase-1 Dysregulation in the Brain: Implications for HIVAssociated Neurocognitive Disorders

, 2014; 12(3): 174 - 188

Surendra S. Ambegaokar and Dennis L. Kolson




β-Catenin/TCF-4 Signaling Regulates Susceptibility of Macrophages and Resistance of Monocytes to HIV-1 Productive Infection

, 2014; 12(3): 164 - 173

Yosra Aljawai, Maureen H. Richards, Melanie S. Seaton, Srinivas D. Narasipura and Lena Al-Harthi




Brain Inflammation is a Common Feature of HIV-Infected Patients without HIV Encephalitis or Productive Brain Infection

, 2014; 12(2): 97 - 110

Eleonora Tavazzi, David Morrison, Peter Sullivan, Susan Morgello and Tracy Fischer




Macrophage Derived Cystatin B/Cathepsin B in HIV Replication and Neuropathogenesis

, 2014; 12(2): 111 - 120

Linda E. Rivera, Krystal Colon, Yisel M. Cantres-Rosario, Frances M. Zenon and Loyda M. Melendez




Outcomes in Older Versus Younger Patients Over 96 Weeks in HIV-1– Infected Patients Treated with Rilpivirine or Efavirenz in ECHO and THRIVE

, 2013; 11(7): 570 - 575

Robert Ryan, Yaswant K. Dayaram, Deborah Schaible, Bruce Coate and David Anderson




Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses

, 2013; 11(5): 378 - 387

Justin Pollara, Mattia Bonsignori, M. Anthony Moody, Marzena Pazgier, Barton F. Haynes and Guido Ferrari




Long-Term Gender-Based Outcomes for Atazanavir/Ritonavir (ATV/r)- Containing Regimens in Treatment-Experienced Patients with HIV

, 2013; 11(4): 333 - 341

Veronica Svedhem-Johansson, Pascal Pugliese, Norbert H. Brockmeyer, Anders Thalme, Claudia Michalik, Stefan Esser, Marie-Helene Barlet, Tina Nakonz and Maria J. Jimenez-Exposito




Opiate Drug Use and the Pathophysiology of NeuroAIDS

, 2012; 10(5): 435 - 452

Kurt F. Hauser, Sylvia Fitting, Seth M. Dever, Elizabeth M. Podhaizer and Pamela E. Knapp




HIV-1 Vpu Interference with Innate Cell-mediated Immune Mechanisms

, 2012; 10(4): 327 - 333

Johan K. Sandberg, Sofia K. Andersson, Susanna M. Bachle, Douglas F. Nixon and Markus Moll




Sites of Action of HIV-1 Vpu in BST-2/Tetherin Downregulation

, 2012; 10(4): 283 - 291

Juan F. Arias, Yukie Iwabu and Kenzo Tokunaga




Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms

, 2011; 9(8): 554 - 567

Jonathan Karn and Uri Mbonye




One Protein to Rule them All: Modulation of Cell Surface Receptors and Molecules by HIV Nef

, 2011; 9(7): 496 - 504

Alessia Landi, Veronica Iannucci, Anouk Van Nuffel, Pieter Meuwissen and Bruno Verhasselt




The Nef-Infectivity Enigma: Mechanisms of Enhanced Lentiviral Infection

, 2011; 9(7): 474 - 489

Jolien Vermeire, Griet Vanbillemont, Wojciech Witkowski and Bruno Verhasselt




Antiretrovirals for Prevention: Realizing the Potential. Closing Commentary by the Executive Director of UNAIDS

, 2011; 9(6): 470 - 472

Michel Sidibe




Antiretroviral Therapy in Prevention of HIV and TB: Update on Current Research Efforts

, 2011; 9(6): 446 - 469

Reuben Granich, Somya Gupta, Amitabh B. Suthar, Caoimhe Smyth, David Hoos, Marco Vitoria, Mariangela Simao, Catherine Hankins, Bernard Schwartlander, Renee Ridzon, Brigitte Bazin, Brian Williams, Ying-Ru Lo, Craig McClure, Julio Montaner and Gottfried Hirnschall




Universal Testing and Treatment as an HIV Prevention Strategy: Research Questions and Methods

, 2011; 9(6): 429 - 445

Richard Hayes, Kalpana Sabapathy and Sarah Fidler




Costing Human Rights and Community Support Interventions as a Part of Universal Access to HIV Treatment and Care in a Southern African Setting

, 2011; 9(6): 416 - 428

Louisa Jones, Paula Akugizibwe, Michaela Clayton, Joseph J. Amon, Miriam Lewis Sabin, Rod Bennett, Christine Stegling, Rachel Baggaley, James G. Kahn, Charles B. Holmes, Navneet Garg, Carla Makhlouf Obermeyer, Christina DeFilippo Mack, Phoebe Williams, Caoimhe Smyth, Marco Vitoria, Siobhan Crowley, Brian Williams, Craig McClure, Reuben Granich and Gottfried Hirnschall




Cost-Effectiveness of Antiretroviral Therapy for Prevention

, 2011; 9(6): 405 - 415

James G. Kahn, Elliot A. Marseille, Rod Bennett, Brian G. Williams and Reuben Granich




Articulating A Rights-Based Approach to HIV Treatment and Prevention Interventions

, 2011; 9(6): 396 - 404

David Barr, Joseph J. Amon and Michaela Clayton




The Unrealized Potential of Addiction Science in Curbing the HIV Epidemic

, 2011; 9(6): 393 - 395

Nora D. Volkow, Ruben D. Baler and Jacques L. Normand




Antiretroviral Treatment as Prevention: Impact of the ‘Test and Treat’ Strategy on the Tuberculosis Epidemic

, 2011; 9(6): 383 - 392

Robin Wood and Stephen D. Lawn




Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV

, 2011; 9(6): 367 - 382

Brian G. Williams, Viviane Lima and Eleanor Gouws




Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis

, 2011; 9(6): 355 - 366

Reuben Granich, Ying-Ru Lo, Amitabh B. Suthar, Marco Vitoria, Rachel Baggaley, Carla Makhlouf Obermeyer, Craig McClure, Yves Souteyrand, Jos Perriens, James G. Kahn, Rod Bennett, Caoimhe Smyth, Brian Williams, Julio Montaner and Gottfried Hirnschall




Acknowledgements and Editorial (Exploring the Role of “Treatment as Prevention”)

, 2011; 9(6): 352 - 354

Marianne Harris and Julio S.G. Montaner




Effects of Tipranavir, Darunavir, and Ritonavir on Platelet Function, Coagulation, and Fibrinolysis in Healthy Volunteers

, 2011; 9(4): 237 - 246

Jens J. Kort, Stella Aslanyan, Joseph Scherer, John P. Sabo, Veronika Kohlbrenner and Patrick Robinson




The Therapeutic Potential of Adenosine Triphosphate as an Immune Modulator in the Treatment of HIV/AIDS: A Combination Approach with HAART

, 2011; 9(4): 209 - 222

Marc C.E. Wagner




Rates of Initial Virological Suppression and Subsequent Virological Failure After Initiating Highly Active Antiretroviral Therapy: The Impact of Aboriginal Ethnicity and Injection Drug Use

, 2010; 8(8): 649 - 658

L. J. Martin, S. Houston, Y. Yasui, T. C. Wild and L. D. Saunders




SHIV Infection Protects Against Heterologous Pathogenic SHIV Challenge in Macaques: A Gold-Standard for HIV-1 Vaccine Development?

, 2009; 7(5): 497 - 503

Robert Sealy, Xiaoyan Zhan, Timothy D. Lockey, Louis Martin, James Blanchard, Vicki Traina-Dorge and Julia L. Hurwitz




What Strategies to Boost Production of Affordable Fixed-Dose Anti-Retroviral Drug Combinations for Children in the Developing World?

, 2007; 5(2): 155 - 187

Daniele Dionisio, Robert Gass, Peter McDermott, Vincenzo Racalbuto, Marina Madeo, Giuseppe Braghieri, Siobhan Crowley, Eloan Dos Santos Pinheiro, Peter Graaff, Ashwin Vasan, Achara Eksaengsri, Helene Moller, Arun Kumar Khanna, Krisana Kraisintu, Sandeep Juneja, Stavros Nicolaou, Aloka Sengupta, Francesco Esperti and Daniela Messeri




Disease Progression in Children with Vertically-Acquired HIV Infection in Sub-Saharan Africa: Reviewing the Need for HIV Treatment

, 2007; 5(2): 139 - 153

Kirsty Little, Claire Thorne, Chewe Luo, Madeleine Bunders, Ngashi Ngongo, Peter McDermott and Marie-Louise Newell




Retrovirus Translation Initiation: Issues and Hypotheses Derived from Study of HIV-1

, 2006; 4(2): 131 - 139

Alper Yilmaz, Cheryl Bolinger and Kathleen Boris-Lawrie




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science